Instrument Inactif

Communiqués Medivation Inc

Actions

US58501N1019

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

28/10/16	Sanofi : relève ses prévisions pour 2016 et s'envole en Bourse	DJ
28/10/16	Sanofi : relève ses prévisions pour 2016 et veut céder ses activités génériques en Europe	DJ

Communiqués

10/10/16	Medivation : De nouvelles données présentées au Congrès 2016 de l’ESMO démontrent une fois de plus que XTANDITM▼ (enzalutamide) améliore nettement, par rapport au placebo, le délai avant progression du PSA en cas de cancer de la prostate avancé	BU
09/10/16	Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo	BU
09/09/16	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Medivation, Inc.	PR
06/09/16	MEDIVATION SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Medivation, Inc. (MDVN) Over the Proposed Sale of the Company to Pfizer Inc.	PR
26/08/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	BU
25/08/16	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders	BU
24/08/16	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Medivation, Inc. -MDVN	PR
23/08/16	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. to Pfizer Inc. is Fair to Shareholders	BU
22/08/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU
22/08/16	Medivation, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Pfizer Inc.	BU
22/08/16	MEDIVATION, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
06/07/16	Purcell Julie & Lefkowitz LLP Is Investigating Medivation, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors	PR
06/07/16	REMINDER: Medivation to Host Conference Call and Webcast Providing Detailed Review of Talazoparib on July 6, 2016	BU
05/07/16	Medivation : Enters into Confidentiality Agreements, Including with Sanofi	BU
24/06/16	Medivation : Glass Lewis Recommends Medivation's Stockholders Support the Company's Current Board	PU
24/06/16	Medivation : Glass Lewis Recommends Medivation’s Stockholders Support the Company’s Current Board	BU
24/06/16	Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi's Misleading Claims	PU
23/06/16	Medivation : Sends Letter to Stockholders to Set the Record Straight on Sanofi’s Misleading Claims	BU
15/06/16	MEDIVATION : INVESTIGATION ALERT – Andrews & Springer LLC Is Investigating Medivation, Inc. For Potential Breaches of Fiduciary Duty - MDVN	BU
13/06/16	Medivation : Files Definitive Consent Revocation Statement and Mails Letter to Stockholders	BU
13/06/16	MEDIVATION : MDVN) Andrews & Springer LLC Is Investigating Medivation, Inc. For Potential Breach of Fiduciary Duty	BU
02/06/16	Medivation : Sets Record Date for Sanofi's Proposed Consent Solicitation	PU
02/06/16	Medivation : Sets Record Date for Sanofi’s Proposed Consent Solicitation	BU
27/05/16	Medivation : Files Preliminary Consent Revocation Statement	BU
25/05/16	Medivation : Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors	PU